Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 31.14
-2.42 (-7.21%)
Apr 20, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Revenue
In the year 2025, Xuanzhu Biopharmaceutical had annual revenue of 51.77M CNY with 72.03% growth. Xuanzhu Biopharmaceutical had revenue of 33.88M in the half year ending December 31, 2025.
Revenue
51.77M CNY
Revenue Growth
+72.03%
P/S Ratio
301.71
Revenue / Employee
262.80K CNY
Employees
197
Market Cap
17.38B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 51.77M | 21.68M | 72.03% |
| Dec 31, 2024 | 30.09M | 30.07M | 103,672.41% |
| Dec 31, 2023 | 29.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition